[Ancient variants of the Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts.]


Journal

Voprosy virusologii
ISSN: 2411-2097
Titre abrégé: Vopr Virusol
Pays: Russia (Federation)
ID NLM: 0417337

Informations de publication

Date de publication:
Historique:
received: 05 03 2020
accepted: 31 03 2020
entrez: 10 6 2020
pubmed: 10 6 2020
medline: 17 4 2021
Statut: ppublish

Résumé

Molecular studies have shown that viruses appeared in the early stages of the evolution of life. For millions of years, viruses have evolved by changing old and acquiring new sequences in their RNA or DNA. It is assumed that most viruses have common ancestors. Such an ancestor, an ancient strain, probably existed for Epstein-Barr virus (EBV) as well. To find out whether ancient strains of EBV persist in modern Russian ethnic groups today. The object of the study was the EBV Analysis of LMP1 sequences from washings of the Slavs oral cavity demonstrated the presence of LMP1 variants with varying degrees of transforming potential: B98.5/A, China1, Med-, and NC. The analysis of LMP1 sequences from washings of Tatar oral cavity also made it possible to identify oncoprotein variants such as B95.8/A, China1, Med-, as well as a group of variants out of classifications (LMP1-OK). An important finding was the identification of 7 variants of LMP1 from Tatars, designated as LMP1-Tat The data obtained allowed us to suggest that: 1) LMP1-Tat

Identifiants

pubmed: 32515563
doi: 10.36233/0507-4088-2020-65-2-77-86
doi:

Substances chimiques

EBV-associated membrane antigen, Epstein-Barr virus 0
Viral Matrix Proteins 0

Types de publication

Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

77-86

Subventions

Organisme : The Ministry of Health of the Russian Federation, The Russian Science Foundation
ID : 18-015-00505А

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

K V Smirnova (KV)

Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Moscow, 115478, Russia.
Pirogov Russian National Research Medical University (RNRMU), Moscow, 117997, Russia.

N B Senyuta (NB)

Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Moscow, 115478, Russia.

A K Lubenskaya (AK)

Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Moscow, 115478, Russia.

T E Dushenkina (TE)

Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Moscow, 115478, Russia.

V E Gurtsevich (VE)

Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Moscow, 115478, Russia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH